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Abstract
African trypanosomes are extracellular parasitic protozoa, predominantly transmitted by the bite of the haematophagic
tsetse fly. The main mechanism considered to mediate parasitemia control in a mammalian host is the continuous
interaction between antibodies and the parasite surface, covered by variant-specific surface glycoproteins. Early
experimental studies have shown that B-cell responses can be strongly protective but are limited by their VSG-specificity.
We have used B-cell (mMT) and IgM-deficient (IgM2/2) mice to investigate the role of B-cells and IgM antibodies in
parasitemia control and the in vivo induction of trypanosomiasis-associated anemia. These infection studies revealed that
that the initial setting of peak levels of parasitemia in Trypanosoma brucei–infected mMT and IgM2/2 mice occurred
independent of the presence of B-cells. However, B-cells helped to periodically reduce circulating parasites levels and were
required for long term survival, while IgM antibodies played only a limited role in this process. Infection-associated anemia,
hypothesized to be mediated by B-cell responses, was induced during infection in mMT mice as well as in IgM2/2 mice, and
as such occurred independently from the infection-induced host antibody response. Antigenic variation, the main immune
evasion mechanism of African trypanosomes, occurred independently from host antibody responses against the parasite’s
ever-changing antigenic glycoprotein coat. Collectively, these results demonstrated that in murine experimental T. brucei
trypanosomiasis, B-cells were crucial for periodic peak parasitemia clearance, whereas parasite-induced IgM antibodies
played only a limited role in the outcome of the infection.
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Introduction
African trypanosomes are extracellular protozoa that cause
chronic infections in humans and livestock and are predominantly
transmitted by the bite of the haematophagic tsetse fly [1].
Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense are the
causative agents of West/Central- and East-African Sleeping
Sickness respectively, also called Human African Trypanosomiasis
(HAT), and are responsible for an estimated 500,000 infection
cases per annum [2]. Trypanosoma congolense, Trypanosoma vivax and
Trypanosoma b. brucei are considered the main cause for livestock
infections. These infections have striking effects on economic
growth, with losses exceeding 1 billion US $/year in Africa [3].
Livestock trypanosomiasis moreover affect public health, as
infected animals serve as a reservoir for tsetse transmission to
humans [2,4].
The main mechanism generally considered to mediate parasit-
emia control in a mammalian host, is the continuous interaction
between antibodies and the parasite surface, covered by variant-
specific surface glycoproteins (VSG) [5]. Trypanosomes undergo
antigenic variation by either changing VSG expression sites,
known as in situ switching of transcriptional control, or by gene
replacement resulting in a switch of the terminal telomeric VSG
gene itself [6,7].
Studies in experimental rodent infection models have implicated
T-cell-independent anti-VSG IgM responses to be the first line of
host defence against proliferating parasites [8]. Experimental
approaches using mice depleted of B-cells by polyclonal antibody
treatment [9], or infections followed by drug-treatment [10], have
shown that B-cell responses can be strongly protective but are
limited by their VSG-specificity. This has recently been confirmed
in a Cape Buffalo model for natural trypanosomiasis resistance
[11]. Recently however, using a chimera bovine model, it was
shown that trypanosomiasis sensitivity or resistance was not solely
linked to the haematopoietic background of the host, suggesting
that other additional host derived factors might also play an
important role in the determination of bovine resistance
phenotypes [12].
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Apart from immune mediated control of infection, the initial
setting of parasitemia levels and waves of successive parasitemia
peaks are regulated by trypanosomes themselves. This coincides
with the differentiation of actively dividing ‘long slender’ parasites
into non-dividing ‘short stumpy’ parasites [1,13–15]. In experi-
mental murine trypanosomiasis infection models, pleomorphic
parasite populations consist of both ‘long slender’ and ‘short
stumpy’ differentiation forms whereas monomorphic populations
consist of ‘long slender’ forms only. The latter is highly virulent
and kills mice rapidly due to the exponential growth of the ‘long
slenders’. The interaction between the different trypanosome
forms and the host immune system can therefore be studied by
performing experimental infections using pleomorphic and
monomorphic trypanosomes that upon infection initially express
the same VSG coat (clonal).
One of the most detrimental consequences of trypanosomiasis is
anemia, which has been described in experimental mouse models
[16–18] and livestock [19,20]. In cattle, monitoring of the
dramatic decrease in packed red cell volume (PCV) is the main
tool for diagnosis of animal trypanosomiasis, only followed later by
parasite detection in the circulation [21]. In human infections, in
particular during the hematolymphatic stage of disease, blood and
serum anomalies including anemia are also commonly present
[22]. However, there is currently a lack of data to explain the
occurrence of trypanosomiasis-associated anemia. Some studies
have suggested infection-induced anti-VSG antibodies are in-
volved in an erythrolytic process [23], whereas other studies have
suggested that trypanosomes release toxic components which
directly lyse red blood cells (RBC) [24]. However, we have
recently shown that the severity of anemia did not correlate with
the actual parasite load [18].
Considering (i) the limited knowledge of the role of individual
antibody isotypes in trypanosomiasis control, and (ii) the unclear
role of B-cells in the in vivo induction of trypanosomiasis-associated
anemia, we used B-cell (mMT) and IgM-deficient (IgM2/2) mice
to address these points. Our results showed that although B-cell-
and IgM-deficient mice infected with the clonal T. brucei AnTat
1.1E parasites exhibited a reduced life span and impaired
parasitaemia clearance, infection-induced IgMs played only a
limited role in host survival during non-clonal infections. In
addition, the presence or absence of B-cells or infection-induced
IgM antibodies did not change the rate of trypanosome surface
antigenic variation nor did it affect the occurrence of infection-
associated anemia. Therefore, our results show that in mice the
overall importance of the infection-induced IgM response is
limited.
Materials and Methods
Animals
Eight to 12 week old female BALB/c mice, BALB/c mMT [25]
mice and IgM-deficient BALB/c (IgM2/2) mice [26], as well as
C57BL/6 and C57BL/6 mMT mice were obtained from an SPF
breeding facility at the University of Cape Town. All mice were
housed in filter-top cages and maintained in SPF barrier facilities
in individual ventilated cages at the University of Cape Town, or
at the Institute for Tropical Medicine Antwerp.
Tsetse flies (Glossina morsitans morsitans) were available from the
insectaria at the Prins Leopold Institute of Tropical Medicine
Antwerp (ITMA), originating from puparia collected in Kariba
(Zimbabwe) and Handeni (Tanzania). Flies were fed on rabbits
and maintained at 26uC and at a relative humidity of 65%.
Animal ethics approval for the tsetse fly feeding on live animals
was obtained from the Animal Ethical Committee of the Institute
of Tropical Medicine, Antwerp (Belgium).
Parasites
The T. brucei brucei AnTat (Antwerp Trypanosoom antigen type)
1.1E, the T. brucei brucei AnTat 1.1 and the non-cloned reference
T. brucei TSW196 parasite stocks were kindly provided by Dr. N.
Van Meirvenne and E. Magnus (Lab. Serology, Institute of
Tropical Medicine (ITG), Antwerp, Belgium) and the MITat 1.2
and 1.4 parasite stocks by Dr. M.A.J. Ferguson (Dept. of
Biochemistry, The University of Dundee, Scotland). The T . b.
brucei AnTat 1.1 clonal, monomorphic parasite strain was
originally generated as a daughter clone of the AnTat 1.1E
clonal, pleomorphic parasite strain. This was done by 25 cycles of
syringe passing on day 4 of infection. Due to the short interval
between passages, the AnTat 1.1 parasite is highly virulent and
expresses only one type of VSG throughout infection, which is
homologous to the initial VSG expressed by the AnTat 1.1E clone.
Similarly, the T. brucei brucei MITat (Molteno Institute Trypano-
zoon antigen type) 1.2 and 1.4 clonal, monomorphic parasites are
highly virulent and express only one VSG that is non-homologous
to the initial VSG expressed by the AnTat 1.1E clone. The
TSW196 T. b. brucei non-clonal, pleomorphic parasite stock was
isolated in 1978 in Coˆte d’Ivoire, from infected pig and was
transferred to an OF1 mice in order to make stabilates for storage
at 280uC. It is catalogued at the ITG as ITMAS300500A. The
AnTaR 1 (Antwerp Trypanozoon antigen repertoire) non-clonal,
pleomorphic parasite strain was isolated in 1966 in Uganda from
the bloodstream of infected bushbuck. Pleomorphic parasite
populations are defined as consisting of both ‘long slender’ and
‘short stumpy’ differentiation forms, whereas monomorphic
parasite populations consist of only ‘long slender’ forms. The
terms clonal and non-clonal indicates that the parasite population
used to infect mice initially express identical or multiple, different
VSGs respectively.
Infection re-challenge, parasitemia & red blood cell
counts
Infections were initiated by intraperitoneal (i.p.) injection of
56103 parasites, unless stated otherwise. Parasites and red blood
cells in a 2.5 ml blood sample 1/200 diluted in PBS, were counted
every 2 to 4 days, using a light microscope. For super-infection
experiments, mice were initially infected with 5000 T. brucei AnTat
1.1E parasites by i.p. injection. On day 6 or day 10 post primary
Author Summary
African trypanosomiasis is a disease caused by different
species of extracellular flagellated protozoan trypanosome
parasites. Trypanosomes have developed a mechanism of
regular antigenic variation of their variant-specific surface
glycoprotein (VSG) coat which allows chronic infection.
Replacement of this coat occurs at rapid regular time
intervals, allowing the parasite to escape from an effective
host antibody responses. So far, primary T-cell indepen-
dent antibody responses have been described to consti-
tute the main host defense mechanism, relying largely on
IgM antibody induction. Using genetically engineered B
lymphocyte- or IgM-deficient mouse strains, we show that
lack of B-cells or IgM did not prevent infection-associated
anemia. More importantly, we show that in the absence of
IgM, parasitemia was controlled almost as well as in wild-
type mice, with only slightly increased mortality. In
addition, we show in vivo that antigenic variation is not
affected by the lack of IgM.
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infection, mice were super-infected with 5000 homologous highly
virulent monomorphic AnTat 1.1 parasites or equally virulent
monomorphic MITat 1.4 parasites. These monomorphic parasites
were capable of expressing only one type of VSG during infection
which were either homologous (AnTat 1.1) or non-homologous
(MITat 1.4) to the VSG initially expressed during primary
infection. For tsetse fly challenge experiments, freshly emerged
tsetse flies were infected by feeding on AnTaR 1 infected mice at
the peak of parasitemia. In order to obtain a pleomorphic
trypanosome population at high titer, these mice were immune
suppressed with cyclophosphamide (20mg/kg). 28 days after the
infecting blood meal, flies were screened for a mature salivary
gland infection by induced probing on pre-warmed glass slides
followed by a microscopic analysis for the presence of metacyclic
trypanosomes in the saliva. Infection of tsetse flies with T. brucei
parasites was performed in compliance with the regulations for
biosafety and under approval from the Environmental adminis-
tration of the Flemish government. To initiate a natural infection,
one individual tsetse fly with a mature salivary gland infection was
allowed to feed per mouse. To avoid interrupted tsetse feeding,
mice were anesthetized prior to the tsetse exposure. Parasite
burden of all mice was monitored every day for 1 week following
super-infection and survival of all mice was recorded. The
experiment was performed in WT BALB/c mice as well is in
BALB/c mMT, and IgM2/2 mice. 10 mice per group were used.
Anti-VSG antibody titer determination by ELISA
Infection-induced anti-VSG titers were determined by ELISA
as described before [27]. Briefly, anti-VSG mouse antibody
isotypes were detected using biotin coupled goat-anti-mouse Ig
isotype antibodies (Pharmingen) in combination with streptavidin
alkaline-phosphatase (AP) for development. Optical density was
determined at 450 nm using a VERSAmax ELISA reader
(Molecular Division).
Quantitative real time RT-PCR
Washed DE52 purified trypanosomes were lysed in TriReagent
(Molecular Research Centre) and total RNA extracted according
to the manufacturer’s instructions. Contaminating genomic DNA
was digested using molecular grade RNase-free DNAse I
(Promega). Reverse transcriptase and cDNA quantification by
real-time PCR on the Lightcycler (Roche Diagnostics) was
performed as recently described [28] using the DNA Master
Hybridization Probe Kit (Roche Diagnostics) according to the
manufacturers instructions. Amplification primers used were: VSG
AnTat 1.1E (GenBank accession X01843): (forward 59-GAA TGC
GAC ACG GAA AGC G-39, reverse 59-CGT CGT TGG CTG
CTT GGA G; 399 base pair product), VSG MITat 1.2 (forward
59-ATG GAC ACC AGC GGA ACA AAC-39, reverse 59-TCC
AGG CGT CGA TCC ACG-39; 259 base pair product), gene
tubulin zeta (GenBank accession AF241275) (forward 59-TCC
CGT CCA TTT CAG GTC C-39, reverse 59-GTG CAT CAG
CAT ACC ATC CAG T-39; 294 base pair product). Specific
hybridization probes for the three genes were respectively VSG
AnTat 1.1E flourescein labeled 59-CTG CT TGC TTG TAG
GTG CTG CCG-39, LC640 59-CGT TAC AGT TGC CAG
TTT AGC TGC GA-39, VSG MITat 1.2 (GenBank accession
X56762) flourescein labeled 59-TAG CGA ACA GCC AAA CAG
CCG TCA C-39, LC705 59- GTC CAG GCG CTC GAT GCA
TTA CAG-39, and (Tubulin zeta) flourescein labeled 59-TGC
CTG TAC CAC CAG CTA AAC TGT GT-39, LC640 59-TAC
CAA AAT TGC CTC AAA CTC CTC CG-39). A standard curve
for AnTat 1.1E, MITat 1.2 and tubulin zeta, was established by
10-fold dilutions of a positive sample and included as a standard
and a ‘‘calibrator control’’. Target mRNA levels in IgM+/+, mMT
and IgM2/2 derived trypanosomes were determined by compar-
ing the sample threshold cycle number against the target gene
standard curve using the Second Derivative Maximum function of
the Lightcycler software (Roche Diagnostics). The same dilutions
of the samples were used for the AnTat 1.1E, MITat 1.2 and
tubulin zeta RT-PCR. AnTat 1.1E VSG levels for each sample
ware normalized by dividing the calculated AnTat 1.1E value by
the calculated tubulin zeta value. The MITat 1.2 RT-PCR served
as negative control on AnTat 1.1E derived mRNA. Fluorescent
data for each sample was detected at the annealing step at 60uC
and hybridization probe specificity cross-checked.
Graphic and statistical result analysis
All graphic result presentations were prepared using GraphPad
Prism software. The same software was used for statistical analysis
of data. Comparative analysis of survival data was done using a
designated GraphPad Prism statistical module using a Logrank
test.
Results
B-cells are essential to prolong survival during African
trypanosomiasis
To address the role of B lymphocytes during experimental
trypanosomiasis, comparative infection studies were performed in
B-cell-deficient (mMT) and WT C57BL/6 mice, using the
pleomorphic T. b. brucei AnTat 1.1E clone. This parasite clone
has been used in the past as a well established model for
experimental trypanosomiasis in mice, and produces a relatively
chronic infection that lasts usually over a month, before killing the
host. The pleomorphic annotation refers to the fact that blood
parasite populations comprise both proliferating ‘long slender’
parasites and ‘short stumpy’ non-proliferating parasites, which are
awaiting transmission to the tsetse fly vector. Figure 1A shows that
in C57BL/6 mice, the absence of B-cells had neither an influence
on the initial growth rate of the trypanosomes, nor on the height of
the parasitemia at 6 days post infection, corresponding to the first
peak in WT mice. Subsequently, post-peak parasite removal and
prolongation of the mean survival of the infected mice were clearly
B-cell dependent (Fig. 1A, B). Important to note is that even in the
absence of any anti-trypanosome antibody response, mice
controlled a slowly but gradually increasing level of infection for
up to 4 weeks. The eventual death of all mMT and WT mice was
associated with exponential parasite proliferation growth, resulting
in parasitemia levels up to 26109 parasites/ml. High parasitemia
before death was largely independent of the genetic background of
the mice, since comparative experimental infections in WT and
mMT deficient mice on either a BALB/c or C57BL/6 background
yielded similar results (Fig. 1 C,D).
Trypanosome-induced IgMs have a limited impact on
host survival
As parasite VSGs rapidly change, primary immunity provided
by T-cell independent IgMs, is believed to confer a crucial impact
on trypanosomiasis control [8,27,29]. In order to test this in vivo,
IgM2/2 and control WT mice were infected with clonal,
pleomorphic T. b. brucei AnTat 1.1E parasites as described above.
Interestingly, in the absence of IgM, mice were able to reduce peak
parasitemia levels, albeit with delayed kinetics and reduced
efficacy as compared to WT controls (Fig. 2A). The reduced
capacity to clear successive parasitemia waves resulted in a slight,
but significant, accelerated mortality (Fig. 2B).
B-Cells and IgM in African Trypanosomiasis
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To evaluate whether changes in intrinsic parasite virulence
affects the importance of antibodies in trypanosomiasis control,
and to mimic natural conditions, tsetse fly infections were used.
Surprisingly, the absence or presence of IgM’s had no impact on
the parasitemia development and survival of mice infected with
AnTaR 1 parasites (Fig. 2C and 2D), which are a non-clonal,
pleomorphic T. b. brucei stock.
In a second attempt to mimic a more natural infection, usually
characterized in cattle by a non-clonal, low-level parasitemia, mice
were infected with non-clonal, pleomorphic T. b. brucei TSW196
parasites derived from a field isolate. When infected with TSW196
parasites, a low virulent infection was obtained in mice. Here
again, no significant differences in parasite burden or mortality
were observed between WT and IgM2/2 mice (Fig. 2E and 2F),
suggesting no significant role for IgM responses against the non-
cloned T. b. brucei TSW196 parasite strain.
IgM2/2 mice produce compensatory soluble IgD
antibodies during trypanosome infections
Antibody binding of the parasite surface is considered to be a
crucial step in protective host mechanism used to neutralize blood
borne parasites. Here, the ability of mice to produce VSG-binding
antibody responses was measured in the presence or absence of
IgM. In WT mice, infection with clonal, pleomorphic AnTat 1.1E
parasites induced rapid VSG-binding IgM antibody serum titers
(Fig. 3) with increasing concentrations towards peak parasitemia
(day 7). VSG-binding IgG2a and IgG3 antibody titers were
detected with a delay of 2 days. Other VSG binding antibody
isotypes were hardly detectable (data not shown). A similar kinetic
for IgG2a and IgG3 was seen in infected IgM2/2 mice. However,
in these mice IgM titers were replaced by compensatory VSG-
binding soluble IgD titers.
IgM antibodies protect against a homologous re-
challenge infection
Previous studies have suggested that during pleomorphic
infections, parasitemia peak clearance involves mainly macro-
phage-mediated removal of non-dividing ‘short stumpy’ parasites
that predominate at this time point [13,30,31]. The antibody
results presented above may suggest that infection-induced IgMs
do contribute to peak parasitemia clearance of clonal parasites. In
order to evaluate the functional activity of antibodies in control of
actively proliferating ‘long slender’ parasites, an infection model
was established using slow killing pleomorphic and fast killing
monomorphic ‘long slender’ T. brucei clones, expressing either
homologous or non-homologous VSGs.
First WT, mMT and IgM2/2 mice were infected with 5000
AnTat 1.1E parasites, resulting in relatively slow mortality kinetics
(Fig. 4A, combining results of Fig. 1D and 2B). In parallel, the
same 3 mouse strains were infected with 5000 highly virulent
monomorphic AnTat 1.1 parasites (expressing only a VSG that
was homologous to the initial VSG of the AnTat 1.1E clone) or
Figure 1. The effect of B-cells in trypanosomiasis control of clonal infections. (A) C57BL/6 WT (#) and mMT (N) mice were infected with a
pleomorphic T. brucei AnTat 1.1E clone by intra-peritoneal inoculation of 5000 parasites. Parasitemia was followed by microscopy analysis of tail-cut
blood samples. Values are presented as mean6SD of 10 individual mice per group. (B) Mortality of all infected mice was recorded. One representative
from 3 experiments is shown. (C,D) The same experiment was performed with BALB/c WT (%) and mMT BALB/c (&) mice. M.S. =median survival time
in days. (*: p,0.0001 compared to WT)
doi:10.1371/journal.ppat.1000122.g001
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with 5000 non-homologous VSG monomorphic MITat 1.4
parasites. Figure 4B shows that both monomorphic parasite clones
kill their WT host within 5 days. Identical results were obtained in
mMT and IgM2/2 mice (data not shown), suggesting that through
their accelerated exponential growth, these parasites have reached
a level of virulence that is lethal before an in vivo efficient B-cell
response can be initiated.
Next, a combination infection model using pleomorphic
parasites for a primary infection, and monomorphic parasites for
a re-challenge infection was established. WT mice were infected
with pleomorphic AnTat 1.1E parasites (Fig. 4C) and on day 6
after primary infection, when the parasite load was greater than
108 parasites/ml (data not shown), they were re-challenged with
5000 monomorphic AnTat 1.1 or MITat 1.4 parasites. These
monomorphic parasites expressed VSGs that were either homol-
ogous (AnTat 1.1) or non-homologous (MITat 1.4) to the initial
VSG expressed during primary infection. This resulted in
significant earlier mortality of re-challenged mice, as compared
to primary infected mice, irrespective of the homology of the VSG
being expressed by the parasite during re-challenge (Fig. 4C)
(p,0.0001). This earlier mortality was triggered by uncontrolled
growth of ‘long slender’ forms of the monomorphic clones
Figure 2. The effect of IgMs in high-, intermediate- or low-virulent infections. BALB/c WT (%) and IgM2/2 (m) mice were infected with (A/B)
5000 parasites of the pleomorphic AnTat 1.1E clone by intra-peritoneal injection, (C/D) non clonal T. brucei AnTaR 1 parasites through exposure to
tsetse fly or (E/F) with 5000 parasites of the low virulent field isolate TSW196 by intra-peritoneal injection. Parasitemia and mortality of infected mice
was assessed as in Fig. 1, using 10 mice per experimental group. M.S. =median survival time.
doi:10.1371/journal.ppat.1000122.g002
B-Cells and IgM in African Trypanosomiasis
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(Fig. 4C), as mice died with high parasitemia exceeding 109
parasites/ml blood after temporary remission of their primary
pleomorphic infection (parasitemia data not shown). However,
when re-challenged at day 10 with monomorphic AnTat 1.1
parasites, expressing homologous VSGs, rapid host killing was not
observed demonstrating VSG-specific resistance (Fig. 4D). Indeed
re-challenge at day 10 with non-homologous VSG expressing
parasites (MITat 1.4) resulted in significantly accelerated mortality
Figure 3. Trypanosome infected IgM2/2mice produce compensatory IgD titers. Sera were collected from T. brucei AnTat 1.1E infected WT
and IgM2/2 BALB/c mice, and were analyzed as serial dilutions (log 10) in a solid phase VSG coated ELISA, using isotype-specific antibodies for
detection. Sera were collected throughout the first peak and clearance phase from 5 individual mice. Values are presented as means.
doi:10.1371/journal.ppat.1000122.g003
B-Cells and IgM in African Trypanosomiasis
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(M.S. = 18 days) as compared to control WT and AnTat 1.1
infected mice (M.S. = 34 days for both groups) (Fig. 4D). However,
the observed host killing occurred with slower kinetics than
observed in Fig. 4B. VSG-specific resistance at day 10 was absent
in mMTmice (Fig. 4E) which displayed a mean survival of 15 days.
This was not unexpected since both monomorphic parasites killed
WT mice within 4–5 days (Fig. 4B). VSG-specific resistance in
IgM2/2 mice re-challenged at the same time point with the same
Figure 4. The role of IgM in VSG-specific protection. (A) BALB/c WT (%), IgM2/2 (m) and mMT (&) mice were infected with 5000 pleomorphic
AnTat 1.1E parasites. (B) BALB/c WT mice were infected with 5000 monomorphic AnTat 1.1 (N) or MITat 1.4 ( ) parasites. (C) AnTat 1.1E infected BALB/
c WT (%) mice were super-infected (S.I.) on day 6 or (D) on day 10 with 5000 parasites of a homologous, monomorphic AnTat 1.1 (N) or a non-
homologous monomorphic, MITat 1.4 ( ) strain. (E) AnTat 1.1E infected BALB/c mMT (%) and (F) BALB/c IgM2/2 (%) mice were super-infected with
AnTat 1.1 (N) or MITat 1.4 ( ) parasites using the same strategy described above in C–D. (G) BALB/c WT (%) and BALB/c nu/nu (.) mice were infected
with 5000 AnTat 1.1E parasites and (H) were super-infected AnTat 1.1 (N) or MITat 1.4 ( ) parasites using the same strategy described above in C–D.
All primary and super-infections were done by intra-peritoneal inoculation of 5000 parasites. Mortality was recorded using 10 mice per experimental
group and the results were compared to mice that only received the primary infection. One out of 3 representative experiments is shown.
doi:10.1371/journal.ppat.1000122.g004
B-Cells and IgM in African Trypanosomiasis
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parasite was significantly impaired as compared to WT mice
(p,0.0001) (Fig. 4D). However, IgM2/2 mice infected with
AnTat 1.1 survived 1 week longer (Fig. 4F) than the 15 days
observed in mMT mice (Fig. 4E). This earlier mortality of IgM2/2
mice as compared to WT mice, showed that IgM’s play only a
minor role in protection against homologous re-challenge
infection. In contrast T-cell deficient mice, which would be
expected to produce T-cell independent anti-VSG IgM antibodies,
were fully protected against homologous challenge (Fig. 4G and
4H).
Antigenic variation occurs in the absence of antibody
responses
Antigenic variation is a characteristic feature of trypanosomes
allowing escape from protective host immune responses. It is
suggested to result in characteristic waves of parasitemia through
interplay with anti-VSG-specific antibodies [32]). Interestingly, the
presence of VSG switching during in vitro cultivation of
trypanosomes under selective drug pressure, demonstrated that
antigenic variation can occur in the absence of antibody mediated
events [33] . However, this is not conclusive for in vivo conditions in
mammals. Due to B-cell mediated selection pressure, one might
expect differences in the overall VSG-specific RNA species.
Quantification of VSG AnTat 1.1E specific RNA by Real Time
RT-PCR from AnTat 1.1E infected B-cell deficient (mMT) or
wild-type mice showed similar VSG AnTat 1.1E specific RNA
concentrations during the first parasitemia peak (Fig. 5A, B). Using
irrelevant VSG MITat 1.2 specific primers, no amplification signal
was obtained under identical real time RT-PCR conditions,
demonstrating the VSG specificity of the assay (data not shown).
VSG AnTat 1.1E specific RNA was undetectable in parasites
isolated from the second peak of parasitemia of WT mice, due to
efficient elimination of the VSG AnTat 1.1E parasites. Interest-
ingly in mMT mice, VSG AnTat 1.1E specific RNA from second
peak parasites was strikingly reduced despite exponential parasite
growth (Fig. 5B), which suggests that the main evasion mechanism
is an intrinsic genetic program. The finding of 3.5 % remaining
VSG AnTat 1.1E specific RNA in mMT-derived parasites
compared to the sensitivity level of .1%, may reflect a slight
reduction in efficiency of clonal parasite elimination in the absence
of antibody-mediated selection pressure. The possibility that a
reduction of VSG AnTat 1.1E specific RNA was due to a
proliferation/growth arrest of parasites could be ruled out as the
total amount of VSG-specific RNA species using quantification by
Uni-primers (able to amplify all VSG RNA species) was similar
during the first and second peak, shown in Fig. 5C. This was
confirmed by microscopy analysis of infected blood of mMT mice
(day 14–22), that contained around 50% dividing ‘long slender’
parasites and 20% non-dividing ‘short stumpy’ parasites (Fig. 5D).
B-cells are not involved in the induction of
trypanosomiasis-associated anemia
Infection-induced anemia is an important morbidity factor in
African trypanosomiasis and has been linked to B-cell responses,
due to lysis of red blood cells after opsonization with VSG-specific
antibodies [23]. However, trypanosomiasis-induced anemia was
as severe in mMT mice as in WT mice (Fig. 6). This was
independent of the mouse genetic background, as similar patterns
of anemia development were recorded in C57BL/6 (Fig. 6A) and
BALB/c mice (Fig. 6B). Furthermore, trypanosomiasis associated
anemia also occurred in the absence of a functional IgM response
(Fig. 6B).
Discussion
African Trypanosomiasis is a textbook example of an
extracellular parasitic infection where antigenic variation of the
variant-specific surface glycoprotein (VSG) and subsequent
antibody responses of the host result in a prolonged period of
parasitemia control [1,3,4,32]. For the parasite, this lengthened
time is required to increase the chance of successful parasite
transmission through the tsetse vector. While resistance to
trypanosomiasis in some mammals such as the Cape Buffalo is
linked to their capacity to mount an efficient anti-parasite
antibody response, trypano-tolerance in cattle can also develop
independently of their genetic haematopoietic background [34].
These observations suggest that besides antibodies, additional host
factors can contribute to parasite control. During the chronic
phase of trypanosomiasis, the continuous interplay between the
parasite and its host’s immune system results in infection-
associated pathology, including anemia [14–20,31–35]. Despite
the importance of anemia, the exact mechanisms underlying its
induction remained unsolved [35]. Some studies, showing that in
vitro VSG-sensitized RBC can be lysed by VSG-specific
antibodies, have suggested that anemia may be linked to B-cell
responses and that antibody mediated lysis may be a contributing
factor in vivo [23]. Other studies have suggested that trypanosomes
themselves release components which directly lyse RBC [24].
Based on in vitro observations, it was proposed that destruction of
RBC’s could occur as a result of an active GPI-VSG transfer
between trypanosome and erythrocyte membranes, followed by
the anti-VSG mediated complement-dependent lysis [23].
However no in vivo data was obtained to support this hypothesis.
Moreover, we have previously not been able to find any
significant correlation between the severity of anemia and parasite
load [18]. Using gene deficient mouse models, we have now
dissected the role of B-cells and IgM-responses in parasite
elimination, host survival, antigenic variation and in Trypanoso-
ma-induced anemia.
We have clearly shown that infected mMT mice still developed
anemia, suggesting that B-cells are not involved in the induction of
trypanosomiasis-associated anemia. This B-cell independent
trypanosomiasis-induced anemia may be mediated by TNF
[18,36,37], although the exact mode of action remains to be
elucidated. TNF could have a crucial impact on anemia through
its capacity to modulate the activation, growth and the phagocytic
potential of macrophages involved in antibody independent
erythrophagocytosis [38–40], a process which is dependent on
IFNc [41].
Infections with clonal, pleomorphic T. brucei parasites (AnTat
1.1E), demonstrated an essential role for B-cells in host protection
and corroborated previous B-cell depletion studies [9,10].
However, IgM was found to play only a limited role in primary
infection with clonal, pleomorphic parasites, perhaps due to the
presence of VSG-specific IgG2a and IgG3 and compensatory IgD
antibodies or other Ig isotypes. Interestingly, our results in BALB/
c mMT and C57BL/6 mMT mice showed that the genetic
background of the host has an impact on parasite growth and
differentiation, independent of the B-cell compartment. Indeed, in
C57BL/6 mMT mice the first parasitemia peak was consistently
lower than the BALB/c mMT, albeit in both strains the peak is
reached at the same time point. Also, since T-cell deficient mice
were found to be fully protected against re-challenge with a
homologous parasite, the antibody mediated VSG-specific pro-
tection observed on day 10 was T-cell independent. However, the
significance of the extended survival of the T-cell deficient mice is
beyond the scope of this paper.
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Figure 5. Quantitative analysis of VSG switching. Switching of VSG expression was followed by real time RT-PCR, by amplification of peak stage
parasite RNA with primers specific for VSG AnTat 1.1E and the housekeeping genes tubulin-zeta (Tubulin). (A) RNA was isolated from WT derived and
(B) mMT derived parasites on the first and second peak, respectively occurring on day 6 and 14. Expression of VSG AnTat 1.1E specific RNA on the
second peak was calculated and compared to the first peak, after normalization of the first and second peak VSG AnTat 1.1E specific RNA to tubulin-
zeta gene expression.. One representative of two experiments are shown. (C) Similarly, total VSG mRNA was amplified from first and second peak mMT
derived parasites, using VSG-Uni primers, and results were normalized using Tubulin gene expression. (D) To assess parasite proliferation in mMT mice,
the occurrence of dividing ‘long slender’ parasites versus intermediate and non-dividing ‘short stumpy’ parasites was analyzed by light microscopy on
day 4 and compared to the chronic infection stage (up to day 22).
doi:10.1371/journal.ppat.1000122.g005
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Re-challenge studies with the homologous monomorphic AnTat
1.1 strain demonstrated that while VSG-specific IgM’s were
induced early during infection, they were not able to efficiently
protect against monomorphic parasites during the first peak of
infection. This was evidenced by the impaired protection in wild-
type mice when re-infected with the homologous VSG-expressing
AnTat 1.1 strain early during infection at day 6 (see Fig. 4C). In
contrast, VSG-specific IgM responses were able to fully protect
WT mice against re-infection at day 10 after primary infection.
However, efficient elimination of actively proliferating monomor-
phic parasites occurred only when the parasites used for re-
challenge expressed a VSG that was homologous to those
expressed during primary infection. These observations support
the notion that antibodies can only exert their full anti-
trypanosome activity in an immunological environment that
develops later than day 6. At this early time point, activated
macrophages play a crucial role in parasite destruction via the
secretion of inflammatory molecules such as nitric oxide (NO) and
TNF, and through phagocytosis of damaged and opsonized
parasites. Although IgM2/2mice survived a few days longer when
re-infected on day 10 with the homologous VSG-expressing
AnTat 1.1 parasite, as compared to re-infection using non-
homologous VSG-expressing MITat 1.4 parasites (Fig. 4F), this
prolonged survival in IgM2/2 mice (MS=12 days) was much less
pronounced than the prolonged survival obtained in WT mice,
where re-challenge on day 10 did not result in accelerated
mortality at all (Fig. 4D). This demonstrated that VSG-specific
IgD and/or IgG responses were not able to efficiently compensate
for IgM immunity, irrespectively of the homology of the VSG
being expressed by the parasite during re-challenge. Because
MITat 1.4 re-challenged IgM2/2 mice (Fig. 4F) survived longer
than MITat 1.4 primary infected IgM2/2 mice (Fig. 4B), we
concluded that a primary host immune responses from day 10,
had a negative effect on parasite growth rate, which seems to be
VSG-independent. A similar observation has been reported in
natural infections where relative resistance or susceptibility to
trypanosomiasis in cattle could not always be correlated to the
host’s capacity of mounting an efficient anti-VSG response.
Instead trypano-tolerance was found to be associated with elevated
Type I cytokine production (IFNc & TNF), increased macrophage
activation and NO production [34,42]. Similarly, during initial
exponential parasite growth phase, SCID mice displayed a
lymphocyte-independent parasite growth regulating mechanism
which gradually triggered the differentiation of proliferating ‘long
slender’ parasites into non-dividing ‘short stumpy’ forms causing
the infection to reach a plateau [13,43]. This mechanism of B-cell
independent parasite control may therefore involve an intrinsic
regulation of parasite growth/differentiation by a parasite released
short-stumpy inducing factor [44].
In contrast to the results from infection using clonal,
pleomorphic parasites, infections with a non-clonal, pleomorphic
field isolate (TSW196) showed that IgM2/2 mice were able to
remit parasitic waves as efficiently as wild-type control mice.
Infection-induced IgM’s may therefore be compensated for,
perhaps by IgG’s or other Ig isotypes, during host protective
responses. Similarly, no prominent role for IgM was observed in
non-clonal tsetse fly initiated infections. However, in this case it
should be noted that the AnTaR 1 T. brucei parasite used for tsetse
fly transmission caused a highly virulent infection in all
experimental groups. Moreover, we can not exclude the possibility
that WT mice do not make sufficient IgM in response to tsetse fly
initiated infections and that IgM’s are important for wave
remission. These results may also suggest that either tsetse fly
saliva components, or other factors involving intrinsic character-
istics of tsetse fly transmitted parasites, actively prevent the
induction of efficient B-cell responses in mice as a defence
mechanism against the host immune system.
Although, previous in vitro experiments indicated that trypano-
somes in culture may undergo VSG switching in the absence of
antibody-mediated pressure [33], this has never been demonstrat-
ed in vivo. We have shown that antigenic variation occurring in vivo
is independent of antibody induction or selective pressure.
Although clonally infected mMT mice had overall impaired
parasite clearance and shortened survival, the virtual absence of
VSG AnTat1.1E specific RNA in mMT mice 10 days after first
peak of infection, demonstrated that parasites switched their VSG
independently of antibody selective pressure. Moreover, the
remaining 3.5% VSG AnTat1.1E specific RNA in mMT mice
and 3% VSG AnTat1.1E specific RNA in IgM-deficient mice,
indicated that antibodies are mostly needed for complete
elimination of the remaining non-switched parasites. Interesting
Figure 6. Trypanosomiasis-associated anemia is present in mMT
mice. (A) C57BL/6 WT (#) and mMT (N) mice were infected with a
pleomorphic T. brucei AnTat 1.1E clone by intra-peritoneal inoculation
of 5000 parasites. (B) BALB/c WT (%), mMT (&) and IgM2/2 (m) mice
were infected by intra-peritoneal inoculation of 5000 with the
pleomorphic AnTat 1.1E clone. RBC counts were followed by
microscopy analysis of tail-cut blood samples. Values are presented as
mean6SD of 10 individual mice per group.
doi:10.1371/journal.ppat.1000122.g006
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to note is the apparently unaltered VSG switching rate between
parasites growing in WT and mMT mice. This observation
suggests that antibody independent host or parasite factors drive
the actual switching process. While the production of a VSG-
specific stumpy-inducing factor by the parasite itself appears
unlikely, it is feasible that inflammatory mediators such as NO,
oxygen radicals or inflammatory cytokines such as TNF and IFNg,
produced by activated macrophages or T-cells could impact on the
activation of antigenic variation. Future repetitions of the
experiments presented here in BALB/c nu/nu and/or RAG2/2
mice could potentially shed more light on the mechanisms at work
here.
In summary, the genetic approach of our study using applicable
gene deficient mice has allowed us to discriminate the in vivo roles
of B-cells as well as IgM-responses in parasite growth control, host
survival and pathology associated with trypanosomiasis. Our
report shows that B-cells are not involved in the induction of
trypanosomiasis-associated anemia. Moreover, although infections
with the clonal, pleomorphic T. brucei AnTat 1.1E parasites in
mMT and IgM2/2 mice indicated a limited role for infection-
induced anti-VSG antibodies in parasitemia control and host
survival. Moreover, non-clonal, low-virulent infections originating
from field populations, as well as tsetse fly exposure experiments,
indicated that IgM responses have no decisive role on either
disease progression or host survival. Finally, this study demon-
strated that in vivo parasite VSG switching operates as an
intrinsically programmed genetic process that is independent of
B-cell or antibody pressure, with the function of antibodies mainly
limited to the elimination of the remaining non-switched parasites.
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